Specify a stock or a cryptocurrency in the search bar to get a summary
Indegene Ltd
INDGNIndegene Limited operates as a life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, and Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technology platforms. Further, it provides analytics, technology, commercial, medical, regulatory, and safety services to life science and healthcare organizations. Indegene Limited was incorporated in 1998 and is based in Bengaluru, India. Address: Manyata Embassy Business Park, Bengaluru, India, 560045
Analytics
WallStreet Target Price
52 205.81 INRP/E ratio
54.5765Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures INDGN
Dividend Analytics INDGN
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History INDGN
Stock Valuation INDGN
Financials INDGN
Results | 2019 | Dynamics |